NO20071397L - 15B-substituted steroids with selective estrogenic activity - Google Patents
15B-substituted steroids with selective estrogenic activityInfo
- Publication number
- NO20071397L NO20071397L NO20071397A NO20071397A NO20071397L NO 20071397 L NO20071397 L NO 20071397L NO 20071397 A NO20071397 A NO 20071397A NO 20071397 A NO20071397 A NO 20071397A NO 20071397 L NO20071397 L NO 20071397L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- estrogenic activity
- substituted steroids
- selective estrogenic
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Oppfinnelsen tilveiebringer 15p-substituerte, steroid-forbindelser som har selektiv østrogenreseptor-aktivitet i henhold til formel I: hvor R1 er H, C1-5-alkyl, C1-12-acyl, di-(C1-5-alkyl)aminokarbonyl, (C1-5-alkyl)oksy-karbonyl eller sulfamoyl, R2 er H, C1-3-alkyl, C2-3-alkenyl eller C2-3-alkynyl, som hver eventuelt kan være substituert med et halogen, R3 er C-1-2-alkyl, etenyl eller etynyl, som hver eventuelt kan være substituert med et halogen, og R4 er H eller C1-12-acyl.The invention provides 15β-substituted steroid compounds having selective estrogen receptor activity according to Formula I: wherein R 1 is H, C 1-5 alkyl, C 1-12 acyl, di- (C 1-5 alkyl) aminocarbonyl, ( C1-5-alkyl) oxy-carbonyl or sulfamoyl, R2 is H, C1-3-alkyl, C2-3-alkenyl or C2-3-alkynyl, each of which may be optionally substituted with a halogen, R3 is C-1- 2-alkyl, ethenyl or ethynyl, each of which may be optionally substituted with a halogen, and R4 is H or C1-12 acyl.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60850104P | 2004-09-08 | 2004-09-08 | |
| EP04104334 | 2004-09-08 | ||
| PCT/EP2005/054368 WO2006027347A1 (en) | 2004-09-08 | 2005-09-05 | 15β-SUBSTITUTED STEROIDS HAVING SELECTIVE ESTROGENIC ACTIVITY |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20071397L true NO20071397L (en) | 2007-04-02 |
Family
ID=35520526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20071397A NO20071397L (en) | 2004-09-08 | 2007-03-15 | 15B-substituted steroids with selective estrogenic activity |
Country Status (9)
| Country | Link |
|---|---|
| KR (1) | KR20070061557A (en) |
| CY (1) | CY1109412T1 (en) |
| DE (1) | DE602005011168D1 (en) |
| EC (1) | ECSP077305A (en) |
| HK (1) | HK1105296A1 (en) |
| HR (1) | HRP20090100T3 (en) |
| IL (1) | IL181334A0 (en) |
| MX (1) | MX2007002815A (en) |
| NO (1) | NO20071397L (en) |
-
2005
- 2005-09-05 MX MX2007002815A patent/MX2007002815A/en active IP Right Grant
- 2005-09-05 DE DE602005011168T patent/DE602005011168D1/en active Active
- 2005-09-05 KR KR1020077007550A patent/KR20070061557A/en not_active Application Discontinuation
-
2007
- 2007-02-14 IL IL181334A patent/IL181334A0/en not_active IP Right Cessation
- 2007-03-08 EC EC2007007305A patent/ECSP077305A/en unknown
- 2007-03-15 NO NO20071397A patent/NO20071397L/en not_active Application Discontinuation
- 2007-12-17 HK HK07113686A patent/HK1105296A1/en not_active IP Right Cessation
-
2009
- 2009-01-23 CY CY20091100087T patent/CY1109412T1/en unknown
- 2009-02-17 HR HR20090100T patent/HRP20090100T3/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2007002815A (en) | 2007-04-30 |
| HRP20090100T3 (en) | 2009-03-31 |
| ECSP077305A (en) | 2007-04-26 |
| IL181334A0 (en) | 2007-07-04 |
| CY1109412T1 (en) | 2014-08-13 |
| KR20070061557A (en) | 2007-06-13 |
| DE602005011168D1 (en) | 2009-01-02 |
| HK1105296A1 (en) | 2008-02-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RS20070075A (en) | 15beta-substituted steroids having selective estrogenic activity | |
| EA200802385A1 (en) | CRYSTAL FORMS 11β- (4-ACETYLPHENYL) -20,20,21,21,21-PENTAFTOR-17-HYDROXY-19-NOR-17A-PREGNA-4,9-DIEN-3-SHE | |
| WO2006072599A3 (en) | Androstane 17-alpha carbonate derivatives for use in the treatment of allergic and inflammatory conditions | |
| NO20054263L (en) | Fluorine and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof | |
| NO20052476D0 (en) | 2-alkyl (2-amino-3-aryl-propionyl) -piperazine derivatives and related compounds as melanocortin receptor ligands for the treatment of obesity. | |
| DE602006017175D1 (en) | 3-BETA-HYDROXY-17- (1H-BENZIMIDAZOLE-1-YL) ANDROSTA-5,16-DIENE FOR THE USE IN THE TREATMENT OF PROSTATE DISEASES | |
| CR9730A (en) | FUNGICIDE BLENDS CONTAINING SUBSTITUTED ANILIDES OF ACID 1-METHYLPIRAZOL-4-ILCARBOXYL | |
| ATE458744T1 (en) | NEW 2-SUBSTITUTED D-HOMO ESTRA-1,3,5(10)-TRIENES AS INHIBITORS OF 17ß-HYDROXYSTEROID DEHYDROGENASE TYPE 1 | |
| NO20062021L (en) | Redirected pentanols, their methods of preparation, and their use as antiflogistics | |
| NO20063479L (en) | Phosphonates, monophosphonamidates and bisphosphonamidates for the treatment of viral diseases | |
| NO20070510L (en) | Methods and Reagents for the Treatment of Metabolic Disorders | |
| WO2005105822A3 (en) | 3-alpha-hydroxy 21-n- heteroaryl-pregnane derivatives for modulation of brain excitability and a process for the production thereof | |
| WO2005018529A3 (en) | Phenoxiacetic acid derivatives | |
| NO20062491L (en) | Benzoxazine derivatives and their use | |
| NO20050720L (en) | Crystal forms of olanzapine and process for their preparation | |
| DE50308933D1 (en) | COMPOSITION, CONTAINING AN ANDROGENIC 11-B HALOGEN STEROIDE AND A STATEMENT AND MALE CONTRAZEPTIVUM BASED ON THIS COMPOSITION | |
| NO20071397L (en) | 15B-substituted steroids with selective estrogenic activity | |
| DE602004007672D1 (en) | PIPERAZINYLCHINOLINE DERIVATIVES SUITABLE FOR THE TREATMENT OF CNS DISEASES | |
| NO20051617L (en) | Piperidine derivatives of heterocycle-fused benzodioxanes with antidepressant activity | |
| ATE295851T1 (en) | NON-AROMATIC ESTROGENIC STEROIDS WITH AN 11-HYDROCARBYL SUBSTITUENT | |
| NO20090646L (en) | Xinafoate salt of a substituted 5-oxazol-2-yl quinoline compound | |
| Phillips et al. | Estra-1, 3, 5 (10), 15-tetraenes. I. Birch Reduction | |
| MY143679A (en) | 15b-subsitituded streoids having selective estrogenic activity | |
| ECSP045180A (en) | PROCESS FOR THE PREPARATION OF 7? -METILESTEROIDS | |
| ATE240346T1 (en) | LIVER-SPECIFIC BILE ACID DERIVATIVES OF THE ANTIGLUCORCORTICOID RU486 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |